OMER Latest Headlines

Omeros Faces European Regulatory Setback Despite U.S. Approval: What’s Next for Narsoplimab’s Global Reach?

Market Chameleon (Fri, 26-Jun 8:36 AM)

Omeros Delivers First Profitable Quarter as YARTEMLEA Launch Transforms Financial Trajectory

Market Chameleon (Thu, 14-May 10:17 AM)

Omeros to Announce Q1 2026 Financial Results Amid Key Product Developments and Novo Nordisk Deal

Market Chameleon (Tue, 12-May 9:39 AM)

Sagimet Biosciences Appoints Former Omeros CMO Andreas Grauer to Strengthen Clinical Leadership

Market Chameleon (Mon, 20-Apr 7:09 AM)

Permanent J-Code Assignment for YARTEMLEA Signals Improved Access and Streamlined Reimbursement for Omeros

Market Chameleon (Thu, 16-Apr 9:24 AM)